factors affecting posology Options
Nonetheless, You will find a minority of cases exactly where the treatment of EID using the ICOC chelation protocol involving DF or L1 or their blend is probably not possible on account of reduced tolerability or toxic Unwanted side effects for example allergic reactions during parenteral infusion of DF or toxicity like L1 agranulocytosis (Desk 1).